Viewing nowNexzol Capsule 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 43.4mg
Prescription medication
BC World Pharmaceutical Co., Ltd.

MFDS item code 201503764 · Approved 2015.06.10
This product's status changed to Approval withdrawn on 2024.01.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment and prevention of gastroesophageal reflux disease, gastrointestinal diseases (ulcers, eradication therapy, etc.), and Zollinger-Ellison syndrome
This medication is used for the treatment and symptom relief of gastroesophageal reflux disease and erosive reflux esophagitis. It is also effective in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori. It is utilized in the treatment and prevention of gastric and duodenal ulcers related to upper gastrointestinal symptoms due to the administration of nonsteroidal anti-inflammatory drugs (NSAIDs). It is also used in the treatment of Zollinger-Ellison syndrome, and can be safely employed for the prevention of rebleeding and as maintenance therapy for gastric or duodenal ulcers. Overall, it is widely used for the treatment and prevention of gastrointestinal-related diseases.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent recurrent symptoms with 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. As-needed use is not recommended for controlling recurrent symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials longer than 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should thereafter be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two daily doses. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous administration Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent recurrent symptoms with 20 mg once daily. 3. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients who have an allergy to this medication or its components, or have a history of hypersensitivity to benzimidazole derivatives, should not use this medication. Furthermore, patients who are taking certain drugs such as terfenadine, cisapride, pimozide, astemizole, atazanavir, nelfinavir, or rilpivirine-containing preparations or breastfeeding mothers should not use this medication. Various adverse reactions can occur with this medication, with common symptoms including headache, abdominal pain, constipation, and diarrhea, and rarely, blood abnormalities, hypersensitivity reactions, hypomagnesemia, mental confusion, skin rashes, and liver dysfunction may occur. Especially with prolonged use, there is an increased risk of hypomagnesemia or fractures, thus regular examinations are necessary. This medication suppresses gastric acid secretion and lowers gastric acidity, which may increase the risk of certain bacterial infections; if gastrointestinal infection symptoms persist, medical consultation is advised. Additionally, this medication may interact with other drugs, so it is essential to inform healthcare professionals of any concomitant medications. For instance, co-administration with warfarin, digoxin, methotrexate, certain antiviral agents, and antibiotics may lead to changes in blood concentration or adverse effects, necessitating caution. Safety during pregnancy or breastfeeding has not been established, so special caution is needed during use. In case of overdose, as there is no specific antidote, appropriate treatment should be sought according to symptoms, and it is important to keep this medication out of reach of children. This medication should be used according to the prescribed dosage and duration, and if there are changes in symptoms or adverse reactions, immediate consultation with healthcare professionals is advised.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized exanthematous pustulosis, eosinophilia and systemic symptom-associated drug reaction, fracture, arthralgia, myalgia, muscle weakness, eosinophilic renal disease, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, general edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, joint disease, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, exacerbated depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbated migraine, sleep disorder, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste disorder, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container, protected from air and moisture. Additionally, the medication should be stored at room temperature, between 1 to 30 degrees Celsius, avoiding excessively hot or cold environments.
A brownish-yellow opaque hard capsule containing white to pale yellow enteric-coated granules.
14 capsules (7 capsules/PTP × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 43.4mg
Prescription medication
BC World Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.